Navigation Links
PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate
Date:11/24/2008

TORONTO, Nov. 24 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: PMD; PREMF.pk) today announced that it has entered into a fully funded collaborative clinical study with one of the world's largest cosmetic companies. PreMD's PREVU* skin cholesterol test will be used in conjunction with one of the cosmetic company's skin care products in a European clinical study. This follows an earlier successful study completed by PreMD with the cosmetic company.

"This is a very positive development for PreMD," said Brent Norton, President and CEO of PreMD. "To engage in collaborations with one of the world's leading cosmetics conglomerates is a significant development which validates our expertise in skin testing, exposes our products' capabilities to new markets, and opens the door to further commercial partnerships. We are excited by the prospect of developing new uses for the product in the cosmetics field and we are hoping to capitalize on these and other opportunities in the near future."

About PreMD Inc.

PreMD Inc. is a leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. PreMD's cardiovascular products include PREVU* POC and PREVU* LT, both non-invasive skin cholesterol tests. The Company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. PreMD's head office is located in Toronto, Ontario and its research and product development facility is at McMaster University in Hamilton, Ontario. For more information about PreMD, please visit www.premdinc.com.

This press release contains forward-looking statements. These statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncerta
'/>"/>

SOURCE PreMD Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
2. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
3. Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
4. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
5. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
6. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
7. ProteoTechs Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimers Disease
8. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
9. Edison Pharma Hits Milestone as A0001 Enters Phase 1 Clinical Development
10. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
11. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)....J.,Nov.25/PRNewswire/--RegadoBiosciences,aprivate...aptamerswithactivecontrolagents,announcedthatDavid...erJaffray21stAnnualHealthCareConferenceattheNewYor...llbegivenat1:10pm(EST)onTuesday,December1andwillin...ntheleaddevelopmentprogram,theanticoagulantsystem,...
(Date:11/25/2009).../PRNewswire/--Reportlinker.comannouncesthatanewmar... MammographyEquipment-AGlobalMarketPerspective ...raphy-Equipment---A-Global-Market-Perspective.html...zedaswellasdevelopingnationsisaprincipalfactorinfl...atingawarenessaboutbreastcancerhasallowedwomentoco...
(Date:11/25/2009)...Nov.25/PRNewswire/--AccordingtoMillenniumResearchG...ketintelligence,thenearly$3billionUSmarketfortraum...enextfiveyearsdespitetherecenteconomicslowdown.MRG...thismarketwillremainhighlydynamicoverthenextfiveye...previouslyunderservedsegmentsofthetraumafixationma...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession 47971 1Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession 47971 2Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession 47971 3Mach One Corporation Developing a Nasal Hand Carried Product as Solution to Swine Flu 28H1N1 29 Virus 12476 1Mach One Corporation Developing a Nasal Hand Carried Product as Solution to Swine Flu 28H1N1 29 Virus 12476 2Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference 12475 1Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference 12475 2
...rch 27 PLC Systems Inc. (OTC Bulletin Board: PLCS...scular medical device-based technologies, today an...trial for RenalGuard(R) will be presented in a pos...Annual Conference, on Sunday, March 29, 2009 at 3:...sented by Dr. Jean-Francois Dorval, of the Brigham...
..., Calif., March 25 Poniard Pharmaceuticals, Inc. ...used on oncology, today announced that it has reac...PEAR (Study of Picoplatin Efficacy After Relapse) ...ating the efficacy and safety of picoplatin in pat... who have failed prior platinum-containing first-l...
Other Medicine Technology:RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009 2RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009 3Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer 2Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer 3Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer 4
(Date:11/27/2009)... Multi-purpose bilingual coloring books designe...he business community to educate - inform parents ...afety issues to Dinosuars to ABC,S and a host of o...s, MO (PRWEB) November 27, 2009 -- Today’s c...o keep them busy any hour of the day, but one of t...
(Date:11/26/2009)..., the number of Americans living with diabetes wil...009 to 44.1 million in 2034. Over the same period,...rom $113 billion to $336 billion, even with no inc...sed at the University of Chicago report in the Dec...those with diabetes covered by Medicare will rise ...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center, a..., is one of a growing number of physicians who are...tes to connect with individuals who are interested... obesity. Dr. Kim is utilizing Facebook to share b...ractice with the community. , ...
(Date:11/25/2009)...,Nov.25/PRNewswire/--TheBartleHallConventionCenter...iconDec.9-10,whenKansasCityhoststhelatestinaseries...sfreecliniceventhasthepotentialtobethebiggestoneye...dbeheldonweekdaysinsteadofoveraweekend,"SheriWood,...dpresidentoftheNationalAssociationofFreeClinics(NA...
(Date:11/25/2009)...d.,Nov.25/PRNewswire-USNewswire/--AnarticlebyJanet...ationandResearch,titled"ADifficultBalance-PainMana...09issueofTheNewEnglandJournalofMedicine. ,, (Lo...DALOGO ) ,, Inthearticle,WoodcockdiscussesFDAef...forthosewhoneeditandmanagingtherisksposedbyvarious...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
...hemists in Jharkhand are refusing to stock the sex... to "berserk and create law and order problems." V...ated waves worldwide for the treatment of erectile...general secretary of the Jharkhand Chemist and Dru...
...octors are advising people to limit themselves to ...ion, as the New Year approaches. A peg or two are ...oke, while excess consumption has the opposite eff...neral, the more alcohol one consumes, the greater ...
...he World Health Organization has issued a statemen...e bird flu samples, collected from recent bird flu...nt of the third bird flu related human death, by B...an, before a week, according to official reports. ...
... research was conducted by the American Researcher...niversity of California, Berkeley. He said that le...rs than to identify varying shades of the same col... to categorize the effect of the perceptible input...
... study was conducted by David Kallmes Neuroradiolo...ent (vertebroplasty) they experience reduced back ...ffective when compared to the other available new ... compression fractures are present. These compress...
...n the King County Medical Examiner's report on 200... deaths, fueled in large part by prescription pain...s annual report on deaths in King County, Statisti...ief medical examiner of King County. Cocaine, m...
Other Medicine News:Health News:Colour Identification Lies Wholly On the Left Hemisphere of the Brain. 2Health News:Improved cure and activity level seen among patients treated by Vertebroplasty. 2Health News:Drug deaths in King County continue to go up 2
Variable Volume Pipette H10
Pipetman P10
Pipetman Ultra U10
... offers improved ergonomics for today's exacting l...rippy finger rest and the large display windows en... Digitals also feature soft-touch tip ejection wit... super blow-out for 0.2 - 50ul micro volume pipett...
Medicine Products: